Sagimet Biosciences Inc.

SGMT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$75,840$75,139$158$56,731
Short-Term Investments$75,410$19,758$32,187$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,524$1,749$447$1,932
Total Curr. Assets$152,774$96,646$32,792$58,663
Property Plant & Equip (Net)$77$73$212$342
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$7,408$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$27$27
Total NC Assets$7,485$73$239$369
Other Assets$0$0$0$0
Total Assets$160,259$96,719$33,031$59,032
Liabilities
Payables$1,425$186$1,125$761
Short-Term Debt$78$65$133$124
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$2,951$5,403$4,021$1,555
Total Curr. Liab.$4,454$5,654$5,279$2,440
LT Debt$0$0$78$224
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$214,624$214,627
Total NC Liab.$0$0$214,702$214,851
Other Liabilities$0$0$0$0
Cap. Leases$78$65$211$348
Total Liabilities$4,454$5,654$219,981$217,291
Equity
Pref Stock$0$0$0$0
Common Stock$3$2$1$1
Retained Earnings-$295,311-$249,744-$221,868-$191,369
AOCI$230$30-$84$0
Other Equity$450,883$340,777$35,001$33,109
Total Equity$155,805$91,065-$186,950-$158,259
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$160,259$96,719$33,031$59,032
Net Debt-$75,762-$75,074$53-$56,383